Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

Top Stories

NATO's $40 Billion Counter-Drone Push Puts These Defense ETFs in Focus
NATO's $40 Billion Counter-Drone Push Puts These Defense ETFs in Focus
Taylor Farms, Sysco Remove Mexico Iceberg Lettuce After FDA Traces Massive Cyclospora Outbreak to Taco Bell Supply Chain
Taylor Farms, Sysco Remove Mexico Iceberg Lettuce After FDA Traces Massive Cyclospora Outbreak to Taco Bell Supply Chain
This New ETF Targets AI Memory Leaders and Weekly Cash Payouts
This New ETF Targets AI Memory Leaders and Weekly Cash Payouts
Taylor Farms, Sysco Remove Mexico Iceberg Lettuce After FDA Traces Massive Cyclospora Outbreak to Taco Bell Supply Chain
Taylor Farms, Sysco Remove Mexico Iceberg Lettuce After FDA Traces Massive Cyclospora Outbreak to Taco Bell Supply Chain
This New ETF Targets AI Memory Leaders and Weekly Cash Payouts
This New ETF Targets AI Memory Leaders and Weekly Cash Payouts
Inflation Broke Lower, The AI Trade Broke with It: The Week on Wall Street
Inflation Broke Lower, The AI Trade Broke with It: The Week on Wall Street
Quantum Stock Meltdown Sends These ETFs Soaring Up to 108%
Quantum Stock Meltdown Sends These ETFs Soaring Up to 108%

Top Stories Recent News

Intuitive Surgical Stock Sinks to 52-Week Low - Here's Why
Intuitive Surgical Stock Sinks to 52-Week Low - Here's Why
Intuitive Surgical ($ISRG) hits 52-week low, dropping 13%. See why 12+ Wall Street firms just cut their price forecasts.
Jeffrey Gundlach Flags Disconnect Between Private Credit CLO Upgrades and Riskier Loan Market
Jeffrey Gundlach Flags Disconnect Between Private Credit CLO Upgrades and Riskier Loan Market
DoubleLine Capital CEO Jeffrey Gundlach is raising questions about whether private credit valuations reflect weakening market conditions.
Why Is Cadence Design Systems Stock Sinking Friday?
Why Is Cadence Design Systems Stock Sinking Friday?
Why did Cadence (CDNS) stock drop 10% on Friday? Inside the broader tech rout, AI disruption fears, and upcoming earnings expectations.
Why Is Kalaris Therapeutics Stock Gaining Friday?
Why Is Kalaris Therapeutics Stock Gaining Friday?
Kalaris Therapeutics (NASDAQ: KLRS) stock jumps 18% after releasing expanded Phase 1a data for its AMD treatment, TH103.
Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion Considers Strategic Alternatives
Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion Considers Strategic Alternatives
Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are happening.
Jasper Closes Kira Deal, Extends Cash Runway
Jasper Closes Kira Deal, Extends Cash Runway
Jasper Therapeutics (JSPR) acquires Kira Pharma & raises $132M, extending its cash runway into 2028. Shares surge 20%+.
Tech Rout Deepens on China's AI Shock, Crude Rises to $81: Stock Market Today
Tech Rout Deepens on China's AI Shock, Crude Rises to $81: Stock Market Today
Semiconductors extend a brutal week after Moonshot AI unveils Kimi K3, while oil jumps 3% on Hormuz renewed disruptions.
Trump Declared The Iran Ceasefire 'Over': These 7 Energy Stocks Have Been Cashing In Ever Since
Trump Declared The Iran Ceasefire 'Over': These 7 Energy Stocks Have Been Cashing In Ever Since
Crude is up 10% since Trump declared the Iran deal over. But refiners — not drillers — lead the 7 best-performing energy stocks. Here's why.
This Novartis Drug Could Help Delay Dialysis—FDA Grants Full Approval
This Novartis Drug Could Help Delay Dialysis—FDA Grants Full Approval
Novartis wins traditional FDA approval for Fabhalta, a first-in-class oral treatment slowing kidney decline in adult IgAN.
Maase Dumps Unmanned Car Wash Business to Double Down on AI
Maase Dumps Unmanned Car Wash Business to Double Down on AI
MaasMaase Inc. (MAAS) stock drops 9% after divesting non-core asset for $17M. Technical analysis shows long-term uptrend intact.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved